KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Cme (CME) over the last 17 years, with Q3 2025 value amounting to 63.25%.

  • Cme's EBIT Margin fell 13900.0% to 63.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.98%, marking a year-over-year increase of 13200.0%. This contributed to the annual value of 64.13% for FY2024, which is 25500.0% up from last year.
  • Cme's EBIT Margin amounted to 63.25% in Q3 2025, which was down 13900.0% from 66.74% recorded in Q2 2025.
  • In the past 5 years, Cme's EBIT Margin registered a high of 67.47% during Q1 2025, and its lowest value of 55.06% during Q4 2021.
  • Moreover, its 5-year median value for EBIT Margin was 61.65% (2023), whereas its average is 61.35%.
  • Within the past 5 years, the most significant YoY rise in Cme's EBIT Margin was 81800bps (2021), while the steepest drop was -52100bps (2021).
  • Cme's EBIT Margin (Quarter) stood at 55.06% in 2021, then grew by 0bps to 55.33% in 2022, then rose by 8bps to 59.97% in 2023, then grew by 4bps to 62.09% in 2024, then increased by 2bps to 63.25% in 2025.
  • Its EBIT Margin stands at 63.25% for Q3 2025, versus 66.74% for Q2 2025 and 67.47% for Q1 2025.